Literature DB >> 27202361

Time Savings With Transtuzumab Subcutaneous (SC) Injection Verse Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 3 Russian Centers.

E De Cock1, Y I Pan2, S Tao2, P Baidin3.   

Abstract

Entities:  

Year:  2014        PMID： 27202361     DOI： 10.1016/j.jval.2014.08.2380

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  4 in total

1.  A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration.

Authors:  Robert J Connor; Barbara Blouw; Jessica Cowell; Kelly Chen; Chunmei Zhao; David W Kang
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-02

2.  A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting.

Authors:  Conor McCloskey; María Toboso Ortega; Sunita Nair; Maria João Garcia; Federico Manevy
Journal:  Pharmacoecon Open       Date:  2022-08-23

3.  Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer.

Authors:  David W Kang; Beate Bittner; Barry J Sugarman; Monica L Zepeda; Marie A Printz
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

Review 4.  Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities.

Authors:  Beate Bittner; Wolfgang Richter; Johannes Schmidt
Journal:  BioDrugs       Date:  2018-10       Impact factor: 5.807
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.